GRI Bio (GRI) Stock: Buy, Sell, or Hold?
$1.82
-0.01 (-0.55%)
▼
5d:
+17.42%
30d:
+30.0%
90d:
+8.98%
QUANTITATIVE VERDICT
WAIT
LOW Confidence (26%)
Quality Score
32/100
Position
EXTENDED
30-Day Fair Range
$1.43 – $1.78
Position: EXTENDED
Forward P/E & Valuation
-0.9x
Next 12M consensus est.
Wall Street Target
$18.50
+916.5% upside
Options IV & Volume
HIGH Vol
HIGH volume confirmation
Support / Resistance
$1.36 / $1.97
Trend: Sideways
Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
📊 MIXED SIGNALS: GRI shows conflicting indicators. Wait for confirmation before entering.
Get Alerted When GRI Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
In-depth Analysis How we analyze
Valuation Analysis: GRI is currently trading at $1.82, which is considered extended relative to its 30-day fair value range of $1.43 to $1.78.
Technical Outlook: Technically, GRI is showing sideways momentum. Immediate support is located at $1.36, while resistance sits at $1.97.
Market Sentiment: GRI scores 3/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $18.50 (+916.5%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, GRI is showing sideways momentum. Immediate support is located at $1.36, while resistance sits at $1.97.
Market Sentiment: GRI scores 3/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $18.50 (+916.5%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$1.43 -
$1.78
Company Quality Score
32/100
(SELL)
Volume Confirmation
HIGH
Confidence Score
26.3%
Trading Range & Key Levels
30-Day Trading Range
$1.43 -
$1.78
Current vs Trading Range
EXTENDED
Support Level
$1.36
Resistance Level
$1.97
Current Trend
Sideways
Technical data as of
Nov 12, 2026
Quantitative Signal Breakdown
- BEARISH: Price extended above range
- BEARISH: Weak technical setup (3/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 916.5% below Wall St target ($18.50)
- WARNING: Composite score 32/100 in the bottom quintile — this cohort historically lags the market
Fundamental Context
Forward P/E (Next Year Est.)
-0.91
Wall Street Target
$18.50
(+916.5%)
Share GRI Analysis
Share this live GRI analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.
bloggers & journalists: you are free to use our charts with attribution.Reddit & Retail Trader Sentiment (GRI)
Neutral
1 Retail Mentions
StockTwits Volume
1 msgs
24h retail stream
Last Tracked
Oct 23, 2026
Daily AI digest
AI Retail Discussion Summary:
Bullish sentiment on StockTwits regarding $GRI with no recent news to report
Key Retail Themes:
Company news or developments
Trader opinions
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams.
View All Trending Reddit & WSB Stocks →
Last updated: November 13, 2026 4:48 AM ET
Data refreshes hourly during market hours. Next update: 5:48 AM
Data refreshes hourly during market hours. Next update: 5:48 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is GRI showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BMRN
Biomarin Pharmaceutical … |
STRONG BUY
28 analysts |
$91 | 53 HOLD |
|
AXSM
Axsome Therapeutics Inc |
STRONG BUY
22 analysts |
$266 | 55 HOLD |
|
INCY
Incyte Corporation |
HOLD
28 analysts |
$132 | 50 HOLD |
|
RAPP
Rapport Therapeutics, In… |
STRONG BUY
16 analysts |
$64 | 48 HOLD |
|
VRDN
Viridian Therapeutics Inc |
STRONG BUY
17 analysts |
$36 | 42 HOLD |
Explore More Analysis & Live Quant Tools
Part A: Deep-Dive GRI Research Pages
